Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2023-10-25 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2023 Third Quarter Report" of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the nine months ending September 30, 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period. It is unaudited, which is common for interim reports. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-25 Chinese
四川千里倍益康医疗科技股份有限公司关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for related party transactions of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the rules, definitions, principles, decision-making authority, disclosure, and voting procedures related to related party transactions. It is a governance-related document outlining internal policies and procedures rather than a financial report or announcement. There is no indication of financial statements, audit results, earnings data, or shareholder voting results. The document is a formal policy approved by the board and pending shareholder approval, which fits the category of Governance Information (CGR).
2023-10-25 Chinese
权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's 2023 third quarter profit distribution plan (dividend distribution proposal). It includes specifics about the dividend amount, the board and supervisory committee's approval, the company's dividend policy, and the procedural steps for approval and implementation. It is not a full financial report but rather a formal announcement of a dividend distribution plan that requires shareholder approval. The document length is 4015 characters, which is relatively short and focused on dividend distribution details. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder details.
2023-10-25 Chinese
四川千里倍益康医疗科技股份有限公司募集资金管理制度
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金管理制度" which translates to "Fundraising Capital Management System" or "Fund Management System". It details the rules, procedures, and governance related to the management and use of funds raised by the company through stock issuance. It includes sections on the storage, use, supervision, and changes to the use of raised funds. The document is a formal policy or system document approved by the board and pending shareholder approval. It is not a financial report, earnings release, or announcement of voting results. It is a regulatory or compliance-related document outlining internal controls and procedures for capital raised. Given the content and nature, it fits best under "Capital/Financing Update" (CAP) as it relates to the management of fundraising proceeds and capital usage policies. The document length is 3614 characters, which is relatively short and detailed, not just an announcement of a report publication. Therefore, the classification is CAP with high confidence.
2023-10-25 Chinese
第三届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the third board of directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other announcements and reports disclosed on the Beijing Stock Exchange information platform. The content focuses on board decisions such as approval of the third quarter report, profit distribution plan, amendments to the company charter, governance system revisions, audit committee member changes, and scheduling of a shareholders meeting. There is no actual financial data or full report content included, only summaries and references to other filings. The document is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and it is not a report itself but an announcement of board decisions.
2023-10-25 Chinese
四川千里倍益康医疗科技股份有限公司审计委员会议事规则
Governance Information Classification · 95% confidence The document is titled '审计委员会议事规则' which translates to 'Audit Committee Meeting Rules'. It details the composition, responsibilities, decision-making procedures, and operational rules of the Audit Committee of the company. It does not contain any financial statements, audit opinions, or results of audits. Instead, it is a governance document outlining the internal rules and structure of the audit committee. The document length is 3870 characters, which is relatively short and focused on governance rather than financial reporting. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.